Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
about
Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: A mini reviewTherapies targeting cancer stem cells: Current trends and future challengesQuercetin-induced miR-200b-3p regulates the mode of self-renewing divisions in pancreatic cancerSulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cellsTriptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine.Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibitionEnrichment of c-Met+ tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinibThe Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.New insights into pancreatic cancer stem cells.Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer.DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell.Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB SignalingTriptolide Upregulates Myocardial Forkhead Helix Transcription Factor p3 Expression and Attenuates Cardiac Hypertrophy.Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-κB-Related Mechanism.The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancerStem cell state and the epithelial-to-mesenchymal transition: Implications for cancer therapy.Control of Apoptosis in Treatment and Biology of Pancreatic Cancer.The role of hypoxia in pancreatic cancer: a potential therapeutic target?Production of Putative Diterpene Carboxylic Acid Intermediates of Triptolide in Yeast.Effects of NF-κB and hypoxia on the biological behavior of Y79 retinoblastoma cells.ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen.Targeting cancer stem cells for chemoprevention of pancreatic cancer.EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression.Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors.Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl.Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.Drug Resistance Driven by Cancer Stem Cells and Their Niche.Triptolide prevents extracellular matrix accumulation in experimental diabetic kidney disease by targeting microRNA-137/Notch1 pathway.Cyclic Depsipeptide BE-43547A2 : Synthesis and Activity against Pancreatic Cancer Stem Cells.Compatibility with Panax notoginseng and Rehmannia glutinosa Alleviates the Hepatotoxicity and Nephrotoxicity of Tripterygium wilfordii via Modulating the Pharmacokinetics of Triptolide.Antitumor effect of triptolide in T-cell lymphoblastic lymphoma by inhibiting cell viability, invasion, and epithelial-mesenchymal transition via regulating the PI3K/AKT/mTOR pathway.miR‑15a represses cancer cell migration and invasion under conditions of hypoxia by targeting and downregulating Bcl‑2 expression in human osteosarcoma cells.Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells.Bisecting N-Acetylglucosamine Structures Inhibit Hypoxia-Induced Epithelial-Mesenchymal Transition in Breast Cancer Cells.Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease
P2860
Q26746015-E63DA2E7-FA63-4891-A051-C8B6A09F83A4Q26777880-4F6899D2-3835-4447-A223-1960E4C055FEQ30836969-E8AB0DF9-FE46-4DC5-A809-2C07F8224B3AQ33637076-4559B1D2-F843-422B-B687-42BD115808A4Q33688875-1E515ADD-C1CD-4272-8E94-71B1131EAC03Q34104182-BB0934F9-FBE4-4793-802D-9E2E4B3ECC41Q34120438-6A2DEF5A-A1CA-4D0B-ADC1-638A20EB7784Q34541663-A67B1D28-E808-47DA-9EE1-109CD88E8E1FQ34690409-487BDEE6-579A-4512-AA66-EE3004523A40Q35501309-17A8A440-5C31-4671-91EF-50E401D750B9Q35833223-4AB421F2-3FBD-4A94-B71E-34E747F57BB4Q36394714-34761137-47D2-4A8A-BC7E-FA800AA1A050Q37036012-CD620E53-5741-4ECC-9D66-92D98523A9E0Q37452461-6F73C37C-0EBC-4206-9625-F2065BF853D1Q37534942-BF78F25E-0656-4CE8-9442-BAABCB4814ADQ37673528-B99972EE-C525-493B-8C25-13345D99D333Q38364522-9B2194F9-14BC-4B8B-8FEF-A5CD6328A6E7Q38553219-CE80EA75-00A5-45AB-97CF-96D9DF8AA2C5Q38631404-484BF185-EE05-4C80-903F-8B4D22CC65B1Q38671568-F09E5770-DA18-45E8-A898-DFFD24B420B8Q38875102-F177A72F-0F4A-4FED-978E-1556071EBF6EQ38945255-C07B67D9-AD96-413B-B6F3-B44729FE9980Q39109832-B6A9E611-9D60-41A9-817C-E1682DA5E30EQ39109931-365095B9-E8B7-4F9E-8F13-D09E6DC4F796Q39205930-08BA57A0-5250-47BC-B920-1C13DF1968C8Q42323428-E69C1985-F925-4B13-9365-A3065BDE6A75Q47144639-7287119E-A401-4AE3-8147-A79A3092E50CQ47169621-838045D5-C22A-4F91-A478-8E38ECFE4B66Q48146490-9708FBB0-142B-408E-9F37-2548B59133A2Q48232893-2FB08648-AF0C-4802-B700-120B704E6341Q49703778-6299694A-58AF-452D-A129-93C307ABE12EQ50333568-A86B72A7-ED99-48E1-A216-F878DEC790AEQ52683999-5D553CFD-7100-4646-9EA9-47917D0C0CC9Q54977044-5CC64FA3-768D-433F-888E-632B97688326Q55401224-2CDAFF16-A718-4816-A6A0-2CEA940487FFQ58758555-1BA2E08F-7F59-4246-93C4-64FE0DAFB4CC
P2860
Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Triptolide reverses hypoxia-in ...... ancer by NF-κB downregulation.
@ast
Triptolide reverses hypoxia-in ...... ancer by NF-κB downregulation.
@en
Triptolide reverses hypoxia-in ...... ancer by NF-κB downregulation.
@nl
type
label
Triptolide reverses hypoxia-in ...... ancer by NF-κB downregulation.
@ast
Triptolide reverses hypoxia-in ...... ancer by NF-κB downregulation.
@en
Triptolide reverses hypoxia-in ...... ancer by NF-κB downregulation.
@nl
prefLabel
Triptolide reverses hypoxia-in ...... ancer by NF-κB downregulation.
@ast
Triptolide reverses hypoxia-in ...... ancer by NF-κB downregulation.
@en
Triptolide reverses hypoxia-in ...... ancer by NF-κB downregulation.
@nl
P2093
P2860
P356
P1476
Triptolide reverses hypoxia-in ...... ancer by NF-κB downregulation.
@en
P2093
Alexei V Salnikov
Clifford Nwaeburu
Ewa Aleksandrowicz
Ingrid Herr
Jens Werner
Jury Gladkich
Jürgen Mattern
Nathalie Bauer
Peter Schemmer
P2860
P304
P356
10.1002/IJC.28583
P577
2014-05-01T00:00:00Z